Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.
about
COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity.Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technologyGonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesGonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesEstrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantationThe role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysisMorphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation.A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage.Frozen embryo transfer prevents the detrimental effect of high estrogen on endometrium receptivity.Serum estradiol levels in controlled ovarian stimulation directly affect the endometrium.Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.Bu Shen Huo Xue decoction restores endometrial leukemia-inhibitory factor but not Angiopoietin-2 expression, and improves uterine receptivity in the controlled ovarian stimulation rat modelDifferent ART outcomes at increasing peak estradiol levels with long and antagonist protocols: retrospective insights from ten years experience.Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles.Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trialDynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatmentGnRH antagonists may affect endometrial receptivity.Day 3 ET, single blastocyst transfer (SBT) or frozen-thawed embryo transfer (FET): which is preferable for high responder patients in IVF/ICSI cycles?Outcome Analysis of Day-3 Frozen Embryo Transfer v/s Fresh Embryo Transfer in Infertility: A Prospective Therapeutic Study in Indian ScenarioEthnicity is an independent predictor of IVF-ICSI outcome: a study of 5,549 cycles in Spain and India.Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study.Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?Is there a detrimental effect of higher gonadotrophin dose on clinical pregnancy rate in normo-responders undergoing ART with long protocol?Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study.Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome.Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles.Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: Which hormone is the main determinant of cycle outcome?Yiqixue buganshen recipe regulates the expression of integrin ανβ3 in the endometrium of controlled ovarian hyperstimulation mice.Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure.A Review of Mechanisms of Implantation.Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice.Effect of anti-PMSG on distribution of estrogen receptor alpha and progesterone receptor in mouse ovary, oviduct and uterus.DS147 improves pregnancy in mice with embryo implantation dysfunction induced by controlled ovarian stimulation.
P2860
Q21145226-65CD6161-9C15-45B8-9B53-5D003EA2489EQ24193015-B0BE2676-AB88-45E8-9D23-83CC69EA9DE2Q24234765-227C4CB7-23B7-4445-B83D-08558E729FCEQ24236630-E3EA08FC-47F2-4E7E-8D1B-D4E1713A4649Q24554244-8D609564-50E3-4D80-B2B2-5615E30CA26CQ24816913-D8DDAF88-76EA-4C71-A012-F8AD0BBC630AQ26800033-B66B5236-8C1A-4891-9120-6C2ED5383795Q32067083-110977A0-7EB6-4CC9-903F-B5CFB1FE4AC7Q33211104-84EA8B94-2BB8-42DE-8436-8157BAF2F8A5Q33743095-AA75EAAC-D9D5-49EB-BBDB-5387B5B0F349Q33904624-A5D30181-7C6F-49FE-9000-20340D166E5AQ34103535-3448CE02-EAE0-40FC-9F93-FBBE2C48339FQ35048373-BFA9F5B3-D1D0-4089-A7CB-B8B513B7D401Q35205814-BB2E89CD-7554-4133-8CDB-00F175B98183Q36268880-85EE8CDE-BE00-40A2-B5F9-4E491A47056CQ36269946-280B0418-E192-4EAC-B940-3E523E1EC908Q36270296-D9D36BAD-432A-4559-8A31-6B1792E05FA5Q36270580-818DA48A-74D0-4C76-9E37-2B517533DC72Q36952561-D5D0CCA8-8459-49B0-AC34-C9538F39DD21Q37037279-3F59D937-E2C7-46A7-93AF-2090AF8919F9Q37235118-FC34BF87-EB97-4DCD-921D-C41EBC195262Q37625664-6FC0B815-2F53-4E79-8D01-864C77B1AB72Q38835016-3B941FC3-835E-4725-9D68-616FF2C09B5BQ39723278-0EF280CF-8AED-4E4D-B140-CBF96A7F9770Q43231828-596A73DE-9A1A-448D-80F3-553692705277Q43293874-3C458440-5051-4DCF-9ED1-95D4F32B120AQ43431688-41449DFE-232B-4B07-82E4-9D81CD2AF24EQ43811117-CB2C2DD1-0543-407A-B6EA-54DE20A1C459Q44013160-FFACD89C-811F-439E-A88F-F98CF16FCA94Q44198601-245E464E-CECA-45F4-9346-AE73900DE14DQ45254003-BA88038B-777B-4297-8755-590D8432B892Q47732121-92E82F14-A7B4-4417-A79B-8F8E3D7B2A23Q47852157-88298A46-BC59-4FB0-B6E4-9DCAFDBA7DC5Q48550093-59847C8B-A095-4588-92D9-BA43E3B0AD51Q48664528-002BBE1E-D95D-4502-903B-06A6054D5E92Q48801120-FC58152E-EA30-4007-AFCF-58683281DFFCQ49511459-204C6E5F-9944-428B-AF83-C9D2FF7FD11EQ50648925-6BFF527E-D0DB-4980-9D90-7A4DC9AA025AQ51116267-F482229A-CE34-47B5-92AC-2A1784CCC6A0Q51219358-7740E815-7239-4860-9556-6729C026C309
P2860
Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Increasing uterine receptivity ...... ing hormone step-down regimen.
@en
Increasing uterine receptivity ...... ing hormone step-down regimen.
@nl
type
label
Increasing uterine receptivity ...... ing hormone step-down regimen.
@en
Increasing uterine receptivity ...... ing hormone step-down regimen.
@nl
prefLabel
Increasing uterine receptivity ...... ing hormone step-down regimen.
@en
Increasing uterine receptivity ...... ing hormone step-down regimen.
@nl
P2093
P1476
Increasing uterine receptivity ...... ing hormone step-down regimen.
@en
P2093
Garcia Velasco JJ
Peinado JA
Pellicer A
Valbuena D
P304
P356
10.1016/S0015-0282(98)00140-X
P407
P50
P577
1998-08-01T00:00:00Z